These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6677006)

  • 21. [120 biopsies of pituitary adenomas studied by immunohistochemistry and electron microscopy. A clinico-pathological correlation].
    Félix IA; Rodríguez Mendoza L; Guinto G; Torres Corzo J; Wussterhaus CA
    Gac Med Mex; 1992; 128(3):289-95. PubMed ID: 1302734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization.
    Lloyd RV; Cano M; Chandler WF; Barkan AL; Horvath E; Kovacs K
    Am J Pathol; 1989 Mar; 134(3):605-13. PubMed ID: 2466405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple pituitary adenomas in Cushing's disease.
    Ratliff JK; Oldfield EH
    J Neurosurg; 2000 Nov; 93(5):753-61. PubMed ID: 11059654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recurrent adenoma of the hypophysis].
    Georgiev ChN; Bozadzhieva EK; Andreeva MKh; Karag'ozov LK; Karag'ozov KL
    Probl Endokrinol (Mosk); 1987; 33(6):28-32. PubMed ID: 3438264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinicomorphological study of pituitary tumors associated with the clinical syndrome of acromegaly.
    Andreeva M; Georgiev T; Bosadjieva E; Karagiosov L; Karagiosov K; Tomova A; Matrosov P; Kirilov G; Diankov L; Christova T
    Exp Clin Endocrinol; 1991; 98(3):223-7. PubMed ID: 1778242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis.
    Schulte HM; Oldfield EH; Allolio B; Katz DA; Berkman RA; Ali IU
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1302-8. PubMed ID: 1720126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Histological peculiarities of the anterior pituitary (presence of adenomas with MSH cells) in 2 cases of Cushing's disease].
    Racadot J; Peillon F; Decourt J; Gilbert-Dreyfus
    Ann Endocrinol (Paris); 1966; 27(1):59-64. PubMed ID: 5937474
    [No Abstract]   [Full Text] [Related]  

  • 28. A clinico-pathologic study of pituitary adenomas.
    Sarkar C; Roy S; Kochupillai N; Gupta N; Tandon PN
    Indian J Med Res; 1990 Oct; 92():315-23. PubMed ID: 2272669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas.
    Dogansen SC; Yalin GY; Tanrikulu S; Tekin S; Nizam N; Bilgic B; Sencer S; Yarman S
    Pituitary; 2018 Aug; 21(4):347-354. PubMed ID: 29460202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Morphology of the paraadenomatous adenohypophysis. A contribution to the pathogenesis of pituitary adenomas (author's transl)].
    Saeger W
    Virchows Arch A Pathol Anat Histol; 1977 Jan; 372(4):299-314. PubMed ID: 139015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cushing's disease and hyperprolactinemia due to a mixed ACTH- and prolactin-secreting pituitary macroadenoma.
    Mahler C; Verhelst J; Klaes R; Trouillas J
    Pathol Res Pract; 1991 Jun; 187(5):598-602. PubMed ID: 1656408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of vasoactive intestinal polypeptide (VIP) on growth hormone (GH) and prolactin (PRL) release and cell morphology in human pituitary adenoma cell cultures.
    Fazekas I; Bácsy E; Varga I; Slowik F; Bálint K; Pásztor E; Czirják S; Gláz E
    Folia Histochem Cytobiol; 2000; 38(3):119-27. PubMed ID: 10970071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unsuspected Cushing's disease in a patient with fatal staphylococcal bacteremia and multiple pituitary adenomas.
    Dunlap NE; Grizzle WE; Heck LW
    Am J Med; 1989 Feb; 86(2):217-21. PubMed ID: 2913787
    [No Abstract]   [Full Text] [Related]  

  • 34. Adrenocorticotropin-secreting pituitary adenomas originate from the anterior or the intermediate lobe in Cushing's disease: differences in the regulation of hormone secretion.
    Lamberts SW; de Lange SA; Stefanko SZ
    J Clin Endocrinol Metab; 1982 Feb; 54(2):286-91. PubMed ID: 6274899
    [No Abstract]   [Full Text] [Related]  

  • 35. 'Silent' somatotropinoma.
    Pawlikowski M; Kuta J; Fuss-Chmielewska J; Winczyk K
    Endokrynol Pol; 2012; 63(2):88-91. PubMed ID: 22538745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro.
    Winczyk K; Kunert-Radek J; Gruszka A; Radek M; Ławnicka H; Pawlikowski M
    Neuro Endocrinol Lett; 2009 Mar; 30(1):107-10. PubMed ID: 19300395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gamma Knife radiosurgery for functioning pituitary adenomas.
    Kim SH; Huh R; Chang JW; Park YG; Chung SS
    Stereotact Funct Neurosurg; 1999; 72 Suppl 1():101-10. PubMed ID: 10681697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone-secreting adenomas: pathology and cell biology.
    Lopes MB
    Neurosurg Focus; 2010 Oct; 29(4):E2. PubMed ID: 20887127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of somatostatin receptors on human pituitary adenomas in vivo and ex vivo.
    Nielsen S; Mellemkjaer S; Rasmussen LM; Ledet T; Olsen N; Bojsen-Møller M; Astrup J; Weeke J; Jørgensen JO
    J Endocrinol Invest; 2001 Jun; 24(6):430-7. PubMed ID: 11434667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comment on: double, synchronous pituitary adenomas causing acromegaly and Cushing's disease. A case report and review of literature. Endocr Pathol 2013;24:92-99.
    Curtò L; Trimarchi F
    Endocr Pathol; 2014 Dec; 25(4):439-40. PubMed ID: 24627186
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.